Displaying 109 - 120 of 496
Immune-Mediated and Cholestatic Diseases

Mirum: Adult Cholestatic Liver Disease: Focusing on Clinical Outcomes and the Future of IBAT Inhibitors (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD's impact on metabolic health and quality of life – new evidence (Complete Session)

Webcasts
View
Public Health and Advocacy

GSK: Are we on the fastest route? From targets to action on hepatitis B in Europe (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IPSEN: The Spectrum of Genetic Cholestasis: The Critical Role of Early Diagnosis and Treatment for Adult Patients (Complete Se...

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC: Innovative Solutions for Today’s Challenges (Complete Session)

Webcasts
View
Viral Hepatitis

AbbVie: Educate, Motivate, Prioritize, Adapt: Decentralizing Care to Eliminate HCV (Complete Session)

Webcasts
View
Cirrhosis & Complications

Gore & Associates: From Covered TIPS to TIPS using Controlled Expansion (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: ​Destination functional cure in CHB: ​What’s driving us ? (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the MASH Paradigm With THR-β Agonists and Other Disease-Specific Therapies

Webcasts
View
Displaying 109 - 120 of 496